Voloridge Investment Management
TBIO

Voloridge Investment Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Voloridge Investment Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,378
Closed -$534K – 1861
2021
Q1 		$534K Buy
32,378
+17,067
+111% +$389K ﹤0.01% 1165
2020
Q4 		$282K Buy
+15,311
New +$274K ﹤0.01% 1230

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Voloridge Investment Management's TBIO Position: Q2 2021 in Review

Voloridge Investment Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 32,378 shares — an estimated $534K sold.

Voloridge Investment Management first reported a position in TBIO in Q4 2020 and held it in 2 quarters. The position peaked at $534K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Voloridge Investment Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 32,378 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $534K.
  • Voloridge Investment Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Voloridge Investment Management's Translate Bio, Inc. Common Stock position peaked at $534K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Voloridge Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.